These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 30270015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-Term Health-Related Quality of Life after Four Common Surgical Treatment Options for Breast Cancer and the Effect of Complications: A Retrospective Patient-Reported Survey among 1871 Patients.
    Kouwenberg CAE, de Ligt KM, Kranenburg LW, Rakhorst H, de Leeuw D, Siesling S, Busschbach JJ, Mureau MAM.
    Plast Reconstr Surg; 2020 Jul; 146(1):1-13. PubMed ID: 32590633
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X, Al Sayah F, Ohinmaa A, Marshall DA, Smith C, Johnson JA.
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [Abstract] [Full Text] [Related]

  • 6. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N, Boonen A, van den Bergh JP, van Kuijk SMJ, Wyers CE, van Oostwaard M, Vranken L, Bours SPG, Hiligsmann M.
    J Med Econ; 2022 Jul; 25(1):829-839. PubMed ID: 35674412
    [Abstract] [Full Text] [Related]

  • 7. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting.
    Cheng Q, Kularatna S, Lee XJ, Graves N, Pacella RE.
    Qual Life Res; 2019 Jul; 28(7):1903-1911. PubMed ID: 30778889
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL, Antunes P, Ferreira LN, Pereira LN, Ramos-Goñi JM.
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [Abstract] [Full Text] [Related]

  • 10. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
    Åström M, Krig S, Ryding S, Cleland N, Rolfson O, Burström K.
    Health Qual Life Outcomes; 2020 Jun 03; 18(1):164. PubMed ID: 32493419
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
    Hagiwara Y, Shiroiwa T, Taira N, Kawahara T, Konomura K, Noto S, Fukuda T, Shimozuma K.
    Health Qual Life Outcomes; 2020 Nov 03; 18(1):354. PubMed ID: 33143687
    [Abstract] [Full Text] [Related]

  • 13. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J.
    Health Qual Life Outcomes; 2016 Sep 20; 14(1):133. PubMed ID: 27644755
    [Abstract] [Full Text] [Related]

  • 14. The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome.
    Sturkenboom R, Keszthelyi D, Brandts L, Weerts ZZRM, Snijkers JTW, Masclee AAM, Essers BAB.
    Qual Life Res; 2022 Apr 20; 31(4):1209-1221. PubMed ID: 34546554
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Testing the Psychometric Properties of 9 Bolt-Ons for the EQ-5D-5L in a General Population Sample.
    Rencz F, Janssen MF.
    Value Health; 2024 Jul 20; 27(7):943-954. PubMed ID: 38599517
    [Abstract] [Full Text] [Related]

  • 17. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y, Devlin N, Herdman M.
    Health Qual Life Outcomes; 2015 Oct 21; 13():171. PubMed ID: 26489956
    [Abstract] [Full Text] [Related]

  • 18. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH, Lang BHH, Yu HMS, Lam CLK.
    Patient; 2017 Aug 21; 10(4):447-454. PubMed ID: 28224296
    [Abstract] [Full Text] [Related]

  • 19. Cost-utility analysis of four common surgical treatment pathways for breast cancer.
    Kouwenberg CAE, Mureau MAM, Kranenburg LW, Rakhorst H, de Leeuw D, Klem TMAL, Koppert LB, Ramos IC, Busschbach JJ.
    Eur J Surg Oncol; 2021 Jun 21; 47(6):1299-1308. PubMed ID: 33349523
    [Abstract] [Full Text] [Related]

  • 20. A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample.
    Nikl A, Janssen MF, Brodszky V, Rencz F.
    Health Qual Life Outcomes; 2023 Feb 19; 21(1):17. PubMed ID: 36803866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.